Article

Ziemer Ophthalmic introduces first rotating dual Scheimpflug analyzer

Lisbon, Portugal – Ziemer Ophthalmic Systems AG, Port Switzerland, introduced the first rotating Dual Scheimpflug Analyzer. Named after Galileo Galilei, the Galilei analyzer is a high-precision optical system for corneal topography and three-dimensional analysis of the anterior segment.

Lisbon, Portugal – Ziemer Ophthalmic Systems AG, Port Switzerland, introduced the first rotating Dual Scheimpflug Analyzer. Named after Galileo Galilei, the Galilei analyzer is a high-precision optical system for corneal topography and three-dimensional analysis of the anterior segment.

According to the company, the Galilei incorporates dual Scheimpflug Imaging and the merging of Placido and Scheimpflug data. Dual Scheimpflug Imaging captures slit lamp images from opposite sides of the illuminated slit lamp, and averages the elevation data obtained from corresponding opposite slit images. This technique improves the detection of the posterior corneal surface and provides for outstanding accuracy in pachymetry across the entire cornea, according to Ziemer Ophthalmic Systems.

The Galilei also features high-resolution slit images of the anterior segment, pachymetry, topography of the cornea and lens, densitometry and chamber analysis. It covers white-to-white and incorporates an adjustable near/far fixation target that allows examination of the anterior chamber, crystalline lens, and any IOLs under near and distance accommodative conditions.

For more information about Galilei, visit Ziemer Ophthalmic Systems at Booth G43.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.